Martin Höglund

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Ingår i European Journal of Haematology, s. 423-432, 2025

• DOI för Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study
• Ladda ner fulltext (pdf) av Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Lennmyr, Emma; Lübking, Anna; Abrahamsson, Marie; Juliusson, Gunnar et al.

Ingår i eJHaem, 2025

• DOI för High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden
• Ladda ner fulltext (pdf) av High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients

Brune, Mats; Kiss, Thomas; Anderson, Harald; Nicklasson, Malin et al.

Ingår i Bone Marrow Transplantation, s. 1676-1682, 2024

• DOI för Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients
• Ladda ner fulltext (pdf) av Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Roeth, Alexander; He, Guangsheng; Tong, Hongyan; Lin, Zenghua et al.

Ingår i American Journal of Hematology, s. 1768-1777, 2024

• DOI för Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
• Ladda ner fulltext (pdf) av Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie et al.

Ingår i Leukemia and Lymphoma, s. 1493-1501, 2024

• DOI för Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
• Ladda ner fulltext (pdf) av Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Ingår i European Journal of Haematology, s. 423-432, 2025

• DOI för Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study
• Ladda ner fulltext (pdf) av Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Lennmyr, Emma; Lübking, Anna; Abrahamsson, Marie; Juliusson, Gunnar et al.

Ingår i eJHaem, 2025

• DOI för High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden
• Ladda ner fulltext (pdf) av High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients

Brune, Mats; Kiss, Thomas; Anderson, Harald; Nicklasson, Malin et al.

Ingår i Bone Marrow Transplantation, s. 1676-1682, 2024

• DOI för Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients
• Ladda ner fulltext (pdf) av Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Roeth, Alexander; He, Guangsheng; Tong, Hongyan; Lin, Zenghua et al.

Ingår i American Journal of Hematology, s. 1768-1777, 2024

• DOI för Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
• Ladda ner fulltext (pdf) av Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie et al.

Ingår i Leukemia and Lymphoma, s. 1493-1501, 2024

• DOI för Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
• Ladda ner fulltext (pdf) av Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Next generation pan-cancer blood proteome profiling using proximity extension assay

Alvez, Maria Bueno; Edfors, Fredrik; von Feilitzen, Kalle; Zwahlen, Martin et al.

Ingår i Nature Communications, 2023

• DOI för Next generation pan-cancer blood proteome profiling using proximity extension assay
• Ladda ner fulltext (pdf) av Next generation pan-cancer blood proteome profiling using proximity extension assay

The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Dahlen, Torsten; Flygt, Hjalmar; Lubking, Anna; Olsson-Strömberg, Ulla et al.

Ingår i Leukemia, s. 1156-1159, 2023

• DOI för The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
• Ladda ner fulltext (pdf) av The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Ingår i Leukemia, s. 550-559, 2023

• DOI för Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Ladda ner fulltext (pdf) av Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Ingår i Haematologica, s. 1015-1025, 2023

• DOI för Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Ladda ner fulltext (pdf) av Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial

Jadersten, Martin; Lilienthal, Ingrid; Tsesmetzis, Nikolaos; Lourda, Magda et al.

Ingår i Journal of Internal Medicine, s. 925-940, 2022

• DOI för Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial
• Ladda ner fulltext (pdf) av Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial

Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators

Larsson, Karin; Soderling, Jonas; Höglund, Martin; Glimelius, Ingrid et al.

Ingår i American Journal of Hematology, 2022

• DOI för Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Ingår i Blood Advances, s. 152-164, 2022

• DOI för Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Ladda ner fulltext (pdf) av Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Österroos, Albin; Maia, Tania; Eriksson, Anna; Jädersten, Martin et al.

Ingår i Haematologica, s. 1528-1537, 2022

• DOI för A risk score based on real-world data to predict early death in acute promyelocytic leukemia
• Ladda ner fulltext (pdf) av A risk score based on real-world data to predict early death in acute promyelocytic leukemia

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Berglund, Eva Caroline; Barbany, Gisela; Orsmark-Pietras, Christina; Fogelstrand, Linda et al.

Ingår i Frontiers in Medicine, 2022

• DOI för A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
• Ladda ner fulltext (pdf) av A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Ingår i New Biotechnology, s. 21-29, 2022

• DOI för Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Ladda ner fulltext (pdf) av Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Bratulic, Sinisa; Limeta, Angelo; Dabestani, Saeed; Birgisson, Helgi et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2022

• DOI för Noninvasive detection of any-stage cancer using free glycosaminoglycans
• Ladda ner fulltext (pdf) av Noninvasive detection of any-stage cancer using free glycosaminoglycans

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study

Dahlen, Torsten; Edgren, Gustaf; Ljungman, Per; Flygt, Hjalmar et al.

Ingår i American Journal of Hematology, s. 421-430, 2022

• DOI för Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study
• Ladda ner fulltext (pdf) av Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study

IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

Huuhtanen, Jani; Ilander, Mette; Yadav, Bhagwan; Dufva, Olli M. J. et al.

Ingår i Journal of Clinical Investigation, 2022

• DOI för IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
• Ladda ner fulltext (pdf) av IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study

Rosso, Aldana; Juliusson, Gunnar; Lorenz, Fryderyk; Lehmann, Sören et al.

Ingår i Leukemia and Lymphoma, s. 1973-1981, 2021

• DOI för Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study
• Ladda ner fulltext (pdf) av Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study

Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study

El-Serafi, Ahmed; He, Rui; Zheng, Wenyi; Benkossou, Fadwa et al.

Ingår i Bone Marrow Transplantation, s. 807-817, 2021

• DOI för Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study

Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Orsmark-Pietras, Christina; Landberg, Niklas; Lorenz, Fryderyk; Uggla, Bertil et al.

Ingår i Genes, Chromosomes and Cancer, s. 426-433, 2021

• DOI för Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
• Ladda ner fulltext (pdf) av Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers

Hernlund, Emma; Redig, Josefine; Paulsson, Bjorn; Derolf, Asa Rangert et al.

Ingår i eJHaem, s. 385-393, 2021

• DOI för Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers
• Ladda ner fulltext (pdf) av Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Ingår i Blood Advances, s. 900-912, 2021

• DOI för Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry

Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; Dremaine, Arta et al.

Ingår i British Journal of Haematology, s. 915-921, 2021

• DOI för Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry
• Ladda ner fulltext (pdf) av Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry

Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology

Venge, Per; Eriksson, Ann-Katrin; Moberg, Lena; Peterson, Christer et al.

Ingår i Scandinavian Journal of Clinical and Laboratory Investigation, s. 307-311, 2021

• DOI för Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology
• Ladda ner fulltext (pdf) av Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology

Impact of treatment delay in acute myeloid leukemia revisited

Juliusson, Gunnar; Hagberg, Oskar; Lazarevic, Vladimir Lj; Lehmann, Sören et al.

Ingår i Blood Advances, s. 787-790, 2021

• DOI för Impact of treatment delay in acute myeloid leukemia revisited

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja et al.

Ingår i Blood Advances, s. 1110-1121, 2021

• DOI för Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Eltahir, mohmo394; Fletcher, E.; Dynesius, L.; Jarblad, J. L. et al.

Ingår i International Immunopharmacology, 2021

• DOI för Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
• Ladda ner fulltext (pdf) av Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Ingår i Growth Factors, s. 189-196, 2021

• DOI för Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2021

• DOI för Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

Larsson, Karin; Mattsson, Mattias; Ebrahim, Fereshte; Glimelius, Ingrid et al.

Ingår i British Journal of Haematology, 2020

• DOI för High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; Cammenga, Jörg et al.

Ingår i British Journal of Haematology, 2020

• DOI för Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael et al.

Ingår i Leukemia, s. 2138-2149, 2020

• DOI för The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
• Ladda ner fulltext (pdf) av The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: a nationwide population-based study

Mattsson, Mattias; Sandin, Fredrik; Kimby, Eva; Höglund, Martin et al.

Ingår i American Journal of Hematology, 2020

• DOI för Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: a nationwide population-based study

The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

Juliusson, Gunnar; Jädersten, Martin; Deneberg, Stefan; Lehmann, Sören et al.

Ingår i Blood Advances, s. 1094-1101, 2020

• DOI för The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays

Kumar, Jagarlamudi Kiran; Holmgren, Sofia; Hamberg Levedahl, Kerstin; Höglund, Martin et al.

Ingår i BioTechniques, s. 335-342, 2020

• DOI för AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays
• Ladda ner fulltext (pdf) av AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays

Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden

Lennmyr, Emma; Karlsson, Karin; Abrahamsson, Marie; Ebrahim, Feresthe et al.

Ingår i European Journal of Haematology, s. 571-580, 2020

• DOI för Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden
• Ladda ner fulltext (pdf) av Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden

Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study

Larfors, Gunnar; Richter, Johan; Själander, Anders; Stenke, Leif et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 151-156, 2020

• DOI för Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study

Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Juliusson, Gunnar; Höglund, Martin; Lehmann, Sören

Ingår i Haematologica, s. 249-251, 2020

• DOI för Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Derolf, Åsa; Juliusson, Gunnar; Benson, Lina; Flöisand, Yngvar et al.

Ingår i British Journal of Haematology, s. 187-191, 2020

• DOI för Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Lubking, Anna; Dreimane, Arta; Sandin, Fredrik; Isaksson, Cecilia et al.

Ingår i Bone Marrow Transplantation, s. 1764-1774, 2019

• DOI för Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Angenendt, Linus; Röllig, Christoph; Montesinos, Pau; Martinez-Cuadron, David et al.

Ingår i Journal of Clinical Oncology, s. 2632-2642, 2019

• DOI för Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

Nilsson, Christer; Hulegardh, Erik; Garelius, Hege; Mollgard, Lars et al.

Ingår i Biology of blood and marrow transplantation, s. 1770-1778, 2019

• DOI för Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Ingår i Acta Oncologica, s. 187-194, 2018

• DOI för U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Ladda ner fulltext (pdf) av U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Gammelgård, Gustav; Wenthe, Jessica et al.

Ingår i Clinical Cancer Research, s. 6185-6194, 2018

• DOI för A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise-a Nationwide Population-Based Study from Sweden

Mattsson, Mattias; Sandin, Fredrik; Kimby, Eva; Höglund, Martin et al.

Ingår i Blood, 2018

• DOI för Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise-a Nationwide Population-Based Study from Sweden

Acute myeloid leukemia in very old patients

Lazarevic, Vladimir Lj; Bredberg, Anders; Lorenz, Fryderyk; Ohlander, Emma et al.

Ingår i Haematologica, 2018

• DOI för Acute myeloid leukemia in very old patients

Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients

Geelen, Inge G. P.; Sandin, Fredrik; Thielen, Noortje; Janssen, Jeroen J. W. M. et al.

Ingår i Leukemia, s. 2299-2303, 2018

• DOI för Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients

Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Eriksson, Anna; Chantzi, Efthymia; Fryknäs, Mårten; Gullbo, Joachim et al.

Ingår i Leukemia Research, s. 41-46, 2017

• DOI för Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
• Ladda ner fulltext (pdf) av Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia

Strese, Sara; Hassan, Saadia Bashir; Velander, Ebba; Haglund, Caroline et al.

Ingår i Oncotarget, s. 6341-6352, 2017

• DOI för In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia

Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia

Jamalpour, Maria; Li, Xiujuan; Cavelier, Lucia; Gustafsson, Karin et al.

Ingår i Tumor Biology, 2017

• DOI för Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia
• Ladda ner fulltext (pdf) av Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia

The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

Larfors, Gunnar; Sandin, Fredrik; Richter, Johan; Själander, Anders et al.

Ingår i European Journal of Haematology, s. 398-406, 2017

• DOI för The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

Reply to D. Pulte et al.

Bower, Hannah; Björkholm, Magnus; Dickman, Paul W; Höglund, Martin et al.

Ingår i Journal of Clinical Oncology, s. 696-697, 2017

• DOI för Reply to D. Pulte et al.

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Juliusson, Gunnar; Abrahamsson, J; Lazarevic, V; Antunovic, P et al.

Ingår i Leukemia, s. 728-731, 2017

• DOI för Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Hoffmann, V S; Baccarani, M; Hasford, J; Castagnetti, F et al.

Ingår i Leukemia, s. 593-601, 2017

• DOI för Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Immunological biomarkers correlate to survival in CAR19-treated patients

Lövgren, Tanja; Wenthe, Jessica; Karlsson, S. C. Hannah; Gammelgård, Gustav et al.

Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Ilander, M; Olsson-Strömberg, Ulla; Schlums, H; Guilhot, J et al.

Ingår i Leukemia, s. 1108-1116, 2017

• DOI för Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
• Ladda ner fulltext (pdf) av Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

Kontro, M; Kumar, A; Majumder, M M; Eldfors, S et al.

Ingår i Leukemia, s. 301-309, 2017

• DOI för HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Lazarevic, Vladimir Lj; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Ingår i European Journal of Haematology, s. 493-500, 2017

• DOI för Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register

Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; Olsson-Strömberg, Ulla et al.

Ingår i European Journal of Haematology, s. 57-66, 2017

• DOI för Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Lehmann, Sören; Deneberg, S.; Antunovic, P.; Rangert-Derolf, A. et al.

Ingår i Leukemia, s. 1457-1459, 2017

• DOI för Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Svensson, Tobias; Lundström, Kristina Lamberg; Höglund, Martin; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, s. 56-60, 2017

• DOI för Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
• Ladda ner fulltext (pdf) av Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

Gunnarsson, N.; Höglund, Martin; Stenke, L.; Sandin, F. et al.

Ingår i Leukemia, s. 1825-1827, 2017

• DOI för No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

A Population-Based Study on First AML Relapse in Sweden

Olsson, Richard; Höglund, Martin; Juliusson, G.

Ingår i Annals of Hematology, 2017

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Blood, s. 1007-1016, 2016

• DOI för Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Österroos, Albin; Kashif, Muhammad; Haglund, Caroline; Blom, Kristin et al.

Ingår i Biochemical Pharmacology, s. 40-49, 2016

• DOI för Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina I.; Essand, Magnus et al.

Ingår i CANCER IMMUNOLOGY RESEARCH, 2016

• DOI för CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Hjorth-Hansen, H.; Stentoft, J.; Richter, J.; Koskenvesa, P. et al.

Ingår i Leukemia, s. 1853-1860, 2016

• DOI för Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence

Gunnarsson, Niklas; Sandin, Fredrik; Höglund, Martin; Stenke, Leif et al.

Ingår i European Journal of Haematology, s. 387-392, 2016

• DOI för Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence

Repositioning Of Quinacrine For Treatment Of Acute Myeloid Leukemia - Synergies And In Vivo Effects

Eriksson, Anna; Gustafsson, Mats; Fryknäs, Mårten; Gullbo, Joachim et al.

Ingår i Haematologica, s. 367-368, 2016

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Wenthe, Jessica; Wikström, Kristina I. et al.

Ingår i Molecular Therapy, 2016

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Gunnarsson, N.; Höglund, Martin; Stenke, L.; Wallberg-Jonsson, S. et al.

Ingår i Leukemia, s. 1562-1567, 2016

• DOI för Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study

Dahlen, Torsten; Edgren, Gustaf; Lambe, Mats; Höglund, Martin et al.

Ingår i Annals of Internal Medicine, s. 161-166, 2016

• DOI för Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Bower, Hannah; Björkholm, Magnus; Dickman, Paul W; Höglund, Martin et al.

Ingår i Journal of Clinical Oncology, s. 2851-2858, 2016

• DOI för Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen; Hermanson, Monica et al.

Ingår i Oncotarget, s. 25109-25120, 2015

• Ladda ner fulltext (pdf) av Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Eriksson, Anna; Österroos, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Ingår i Blood Cancer Journal, 2015

• DOI för Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
• Ladda ner fulltext (pdf) av Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Haematologica, s. 10-11, 2015

The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Christiansson, Lisa; Söderlund, Stina; Mangsbo, Sara; Hjorth-Hansen, Henrik et al.

Ingår i Molecular Cancer Therapeutics, s. 1181-1191, 2015

• DOI för The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Ingår i Journal of Rheumatology, s. 690-694, 2015

• DOI för Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Lazarevic, Vladimir; Hörstedt, Ann-Sofi; Johansson, Bertil; Antunovic, Petar et al.

Ingår i European Journal of Haematology, s. 419-423, 2015

• DOI för Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Hulegårdh, Erik; Nilsson, Christer; Lazarevic, Vladimir; Garelius, Hege et al.

Ingår i American Journal of Hematology, s. 208-214, 2015

• DOI för Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Ohm, Lotta; Lundqvist, Adam; Dickman, Paul; Höglund, Martin et al.

Ingår i Leukemia and Lymphoma, s. 1385-1391, 2015

• DOI för Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

Hjorth-Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta et al.

Ingår i European Journal of Haematology, s. 243-250, 2015

• DOI för Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
• Ladda ner fulltext (pdf) av Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Gunnarsson, Niklas; Stenke, Leif; Höglund, Martin; Sandin, Fredrik et al.

Ingår i British Journal of Haematology, s. 683-688, 2015

• DOI för Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

Lazarevic, Vladimir; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Ingår i American Journal of Hematology, s. 800-805, 2015

• DOI för Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

PROGRESSION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TO ADVANCED PHASE ON TKI THERAPY: A POPULATION BASED ANALYSIS FROM THE SWEDISH CML REGISTER

Söderlund, Stina; Dahlen, T.; Creignou, M.; Sandin, F. et al.

Ingår i Haematologica, s. 233-233, 2015

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina; Essand, Magnus et al.

Ingår i Blood, 2015

Mature, Adaptive-like CD56(DIM) NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Ilander, Mette; Schlums, Heinrich; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna et al.

Ingår i Blood, 2015

Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients

Hjorth-Hansen, Henrik; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu et al.

Ingår i Blood, 2015

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Gunnarsson, Niklas; Höglund, Martin; Stenke, Leif; Jonsson, Solveig Wallberg et al.

Ingår i Blood, 2015

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Juliusson, Gunnar; Lazarevic, Vladimir; Antunovic, Petar; Derolf, Asa Rangert et al.

Ingår i Blood, 2015

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Deneberg, Stefan; Lundin, Ebba; Lazarevic, Vladimir; Benson, Lina et al.

Ingår i Blood, 2015

Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study

Björkholm, Magnus; Bower, Hannah; Dickman, Paul W.; Lambert, Paul C. et al.

Ingår i Blood, 2015

Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Lotfi, Kourosh; Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen et al.

Ingår i Cancer Research, 2015

• DOI för Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Qu, Ying; Lennartsson, Andreas; Gaidzik, Verena I.; Deneberg, Stefan et al.

Ingår i Epigenetics, s. 1108-1119, 2014

• DOI för Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

Lazarevic, V.; Horstedt, A-S; Johansson, B.; Antunovic, P. et al.

Ingår i Blood Cancer Journal, 2014

• DOI för Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience
• Ladda ner fulltext (pdf) av Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Eriksson, Anna; Kalushkova, Antonia; Jarvius, Malin; Hilhorst, Riet et al.

Ingår i Biochemical Pharmacology, s. 284-291, 2014

• DOI för AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
• Ladda ner fulltext (pdf) av AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Genovese, Giulio; Kaehler, Anna K.; Handsaker, Robert E.; Lindberg, Johan et al.

Ingår i New England Journal of Medicine, s. 2477-2487, 2014

• DOI för Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

Ilander, Mette; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna; Kasanen, Tiina et al.

Ingår i Scandinavian Journal of Immunology, s. 467-468, 2014

Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

Lundberg, Johan; Höglund, Martin; Bjorkholm, Magnus; Akerborg, Orjan

Ingår i Clinical drug investigation, s. 483-489, 2014

• DOI för Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Ingår i British Journal of Haematology, s. 671-680, 2014

• DOI för Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia. Data from Swedish Population-Based Registries

Dahlen, Torsten; Edgren, Gustaf; Höglund, Martin; Lambe, Mats et al.

Ingår i Blood, 2014

Targeted RNA Sequencing Assay Efficiently Identifies Cryptic KMT2A (MLL)-Fusions in Acute Leukemia Patients

Sevov, Marie; Bunikis, Ignas; Häggqvist, Susana; Höglund, Martin et al.

Ingår i Blood, 2014

Incidence of CML in Europe -- a Comparison of 19 European Countries with US SEER Data

Hoffmann, Verena S.; Lindoerfer, Doris; Thaler, Josef; Boris, Labar et al.

Ingår i Blood, 2014

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Ilander, Mette Matilda; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna; Tiina, Kasanen et al.

Ingår i Blood, 2014

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Juliusson, Gunnar; Lazarevic, Vladimir; Lehmann, Soren; Derolf, Asa Rangert et al.

Ingår i Blood, 2014

Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia

Eriksson, Anna; Osterros, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Ingår i Blood, 2014

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Nilsson, Christer; Hulegardh, Erik; Lazarevic, Vladimir; Garelius, Hege et al.

Ingår i Blood, 2014

Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Gunnarsson, Niklas; Leif, Stenke; Höglund, Martin; Sandin, Fredrik et al.

Ingår i Blood, 2014

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Höglund, Martin; Sandin, Fredrik; Hellstrom, Karin; Bjoreman, Mats et al.

Ingår i Blood, s. 1284-1292, 2013

• DOI för Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Svensson, Tobias; Cherif, Honar; Höglund, Martin

Ingår i Scandinavian Journal of Infectious Diseases, s. 730-730, 2013

• DOI för Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Svensson, Tobias; Höglund, Martin; Cherif, Honar

Ingår i Scandinavian Journal of Infectious Diseases, s. 537-542, 2013

• DOI för Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i European Journal of Haematology, s. 413-419, 2013

• DOI för Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cost-Utility Analysis Of Posaconazole Versus Fluconazole For Prevention Of Invasive Fungal Infections In Patients With Graft-Versus- Host Disease In Sweden

Lundberg, J. G.; Jensen, A. ; Bjorkholm, M.; Höglund, Martin et al.

Ingår i Value in Health, 2013

• DOI för Cost-Utility Analysis Of Posaconazole Versus Fluconazole For Prevention Of Invasive Fungal Infections In Patients With Graft-Versus- Host Disease In Sweden

Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Ingår i American Journal of Hematology, s. 1001-1006, 2013

• DOI för Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

Falk, Ingrid Jakobsen; Fyrberg, Anna; Hermanson, Monica; Höglund, Martin et al.

Ingår i Cancer Research, 2013

• DOI för Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, Anna; Hermanson, Monica; Wickström, Malin; Lindhagen, Elin et al.

Ingår i Blood Cancer Journal, 2012

• DOI för The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

Haglund, Caroline; Åleskog, Anna; Nygren, Peter; Gullbo, Joachim et al.

Ingår i Cancer Chemotherapy and Pharmacology, s. 697-707, 2012

• DOI för In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Armuand, Gabriela M.; Rodriguez-Wallberg, Kenny A.; Wettergren, Lena; Ahlgren, Johan et al.

Ingår i Journal of Clinical Oncology, s. 2147-2153, 2012

• DOI för Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Acute myeloid leukemia in the real world: why population-based registries are needed

Juliusson, Gunnar; Lazarevic, Vladimir; Hörstedt, Ann-Sofi; Hagberg, Oskar et al.

Ingår i Blood, s. 3890-3899, 2012

• DOI för Acute myeloid leukemia in the real world: why population-based registries are needed

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i Blood, s. 1054, 2012

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Lehmann, Soren; Lazarevic, Vladimir; Horstedt, Ann-Sofi; Hulegardh, Erik et al.

Ingår i Blood, s. 130, 2012

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Juliusson, Gunnar; Karlsson, Karin; Lazarevic, Vladimir Lj; Wahlin, Anders et al.

Ingår i Cancer, s. 4238-4246, 2011

• DOI för Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Pregnancy and risk of acute myeloid leukaemia: a case-control study

Larfors, Gunnar; Höglund, Martin; Cnattingius, Sven

Ingår i European Journal of Haematology, s. 169-171, 2011

• DOI för Pregnancy and risk of acute myeloid leukaemia: a case-control study

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Eriksson, Anna; Höglund, Martin; Lindhagen, Elin; Åleskog, Anna et al.

Ingår i Biochemical Pharmacology, s. 1507-1516, 2010

• DOI för Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph plus ALL receiving dasatinib

Olsson-Strömberg, Ulla; Hermansson, Monica; Lundan, Tuija; Ohm, Anne-Charlotte et al.

Ingår i European Journal of Haematology, s. 399-404, 2010

• DOI för Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph plus ALL receiving dasatinib

Epidemiology of chronic myeloid leukaemia: an update

Höglund, Martin; Sandin, Fredrik; Simonsson, Bengt

Ingår i Annals of Hematology, 2015

• DOI för Epidemiology of chronic myeloid leukaemia: an update

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Ladda ner fulltext (pdf) av SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Isolated subclonal mutations are not a common feature in untreated chronic lymphocytic leukemia

Larsson, Karin; Young, Emma; Höglund, Martin; Mattsson, Mattias et al.